Dieter Gericke

Dieter Gericke represents public and private companies and investors of all industries in international mergers, acquisitions,takeovers, divestitures, spin offs, joint ventures, private equity and capital mar-ket transactions. Dieter has also extensive experience in corporate governance, shareholder activism, takeover defense and contested acquisitions, and is a go-to lawyer for IPOs.

• Advising CSL in the public take-over of Vifor Pharma
• Advising ChemChina in the public takeover of Syngenta
• Advising EF in the sale of its China kids business
• Advising Therachon in the sale to Pfizer
• Advising Meyer Burger in a proxy fight and capital increase
• SoftwareOne in the unsolicited approach by Bain Capital
• Tencent on its investments in Global Blue
• Bobst Group in the take private by JBF Finance
• KKR in the acquisition of Biosynth
• Bühler in the acquisition of Haas Group
• Givaudan in the acquisition of Induchem
• Infront Sports & Media in the sale to Dalian Wanda or Nestlé in the sale of Alcon to Novartis

• Capital markets: Equity
• M&A
• Private equity
• Restructuring and insolvency

• Financial services
• Food and beverage
• Industrials
• Pharma and life sciences
• Tech and telecoms

• At all Swiss courts

• Zurich Bar Association
• International Bar Association (Corporate and M&A Law Committee, Securities Law Committee)

• lic. iur., University of Zurich, (1991)
• Dr. iur., University of Zurich, (1996)
• LL.M., Harvard Law School, (1999)